Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000803565 | SCV000943443 | pathogenic | Tuberous sclerosis 1 | 2018-11-10 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser575Alafs*57) in the TSC1 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in TSC1 are known to be pathogenic (PMID: 10227394, 17304050). This variant has not been reported in the literature in individuals with TSC1-related disease. |
Baylor Genetics | RCV001292920 | SCV001481618 | pathogenic | Lymphangiomyomatosis | 2018-10-30 | criteria provided, single submitter | clinical testing | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. |
Genome- |
RCV000803565 | SCV002040964 | pathogenic | Tuberous sclerosis 1 | 2021-11-07 | criteria provided, single submitter | clinical testing |